| 000 | 01789nam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030229.0 | ||
| 008 | 100520s2010 ua f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.10.M.Sc.2010.Al.P | ||
| 100 | 0 | _aAliaa Ibrahim Abdelazeem Daker | |
| 245 | 1 | 4 |
_aThe prevalence of dermatologic manifestations related to chronic hepatitis C virus infection / _cAliaa Ibrahim Abdelazeem Daker ; Supervised Nahla Shoukry Hunter , Nermine Hamdi Eleishi , Doaa Ahmed Elderwi |
| 246 | 1 | 5 | _aمعدل انتشار الأمراض الجلدية فى مرضى الالتهاب الكبدى الفيروسى سى المزمن |
| 260 |
_aCairo : _bAliaa Ibrahim Abdelazeem Daker , _c2010 |
||
| 300 |
_a141 P. ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and venerology | ||
| 520 | _aThe hepatitis C virus (HCV ) is a major public health problem all over the world with a global prevalence of 3% . It is responsible for 70% of cases with chronoc hepatitis the major cause of cirrhosis and the most common cause of hepatocelluar carcinoma . The current treatment of chronic hepatitis C is the combination of interferon alpha and ribavirin with the sustained treatment response range of 56 - 82% | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDermatologic | |
| 653 | 4 | _aExtrahepatic | |
| 653 | 4 | _aHepatitis C infection | |
| 700 | 0 |
_aDoaa Ahmed Elderwi , _eSupervisor |
|
| 700 | 0 |
_aNahla Shoukry Hunter , _eSupervisor |
|
| 700 | 0 |
_aNermine Hamdi Eleishi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c30358 _d30358 |
||